Nayara, which builds clinical-grade AI companions that support patients between appointments, has closed a pre-seed round led by SFC Capital.
Only around 10% of healthcare takes place in the hospital. In the other 90%, patients are often left to navigate medical questions, uncertainty and anxiety on their own, while clinical teams are overwhelmed by routine enquiries and have limited insight into how patients are progressing outside the clinic. Nayara serves hospitals, health systems and medical technology companies with AI companions that answer routine patient questions, give personalised guidance and emotional support, and check in with patients between appointments. The platform identifies concerns and requests that need a provider's attention and routes them to the appropriate team. For healthcare teams, that means less time spent on repetitive enquiries and clearer visibility of patients' needs, helping them prioritise follow-up and support more patients with existing resources.
Gal Moore, CEO, and Rami Kahan, Chief Commercial Officer, co-founded Nayara, which brings together medical professionals, patients, people who have supported loved ones through illness and AI engineers. Its technology is already used across clinical pathways including oncology, where its breast cancer companion has supported hundreds of patients. The funding will accelerate product development, clinical validation and commercial expansion.
Technology has transformed what medicine can achieve, but the way we support patients has struggled to keep pace. We started Nayara with a simple belief: no patient should feel alone in their healthcare journey. No warning sign should go unaddressed because the clinical team lacked the information, or the time, to act.
We see tremendous potential in Nayara's vision and the team's ability to execute. As healthcare systems face mounting pressure, solutions that can deliver meaningful improvements for both patients and providers represent an exciting investment opportunity. We're delighted to support Nayara in its next stage of growth.
